Evidence map›Paper›PMID 32299365›Full record

ArticleBMC immunology2020

Ionizing radiation modulates the phenotype and function of human CD4+ induced regulatory T cells.

Samantha S Beauford, Anita Kumari, Charlie Garnett-Benson

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in BMC immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Regulatory T cells in cancer and inflammation.Signal transduction and targeted therapy · 2026
    Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Translational Frontiers and Clinical Opportunities of Immunologically Fitted Radiotherapy.Clinical cancer research : an official journal of the American Association for Cancer Research · 2024
    Review
  13. Review
  14. The Role of Regulatory T Cells in Cancer Treatment Resistance.International journal of molecular sciences · 2023
    Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Samantha S BeaufordDepartment of Biology, Georgia State University, 161 Jesse Hill Jr. Dr, Atlanta, GA, 30303, USA.
Anita KumariDepartment of Biology, Georgia State University, 161 Jesse Hill Jr. Dr, Atlanta, GA, 30303, USA.
Charlie Garnett-BensonDepartment of Biology, Georgia State University, 161 Jesse Hill Jr. Dr, Atlanta, GA, 30303, USA. cgarnettbenson@gsu.edu.
Georgia State University · US

Funding

American Cancer Society RSG-15-182-01
6 · The paper itself

Abstract

backgroundThe use of immunotherapy strategies for the treatment of advanced cancer is rapidly increasing. Most immunotherapies rely on induction of CD8+ tumor-specific cytotoxic T cells that are capable of directly killing cancer cells. Tumors, however, utilize a variety of mechanisms that can suppress anti-tumor immunity. CD4+ regulatory T cells can directly inhibit cytotoxic T cell activity and these cells can be recruited, or induced, by cancer cells allowing escape from immune attack. The use of ionizing radiation as a treatment for cancer has been shown to enhance anti-tumor immunity by several mechanisms including immunogenic tumor cell death and phenotypic modulation of tumor cells. Less is known about the impact of radiation directly on suppressive regulatory T cells. In this study we investigate the direct effect of radiation on human T

resultsBoth natural and TGF-β1-induced CD4+ T

conclusionsOur findings demonstrate that while human T

Indexed as

CD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCell DeathCells, CulturedCTLA-4 AntigenForkhead Transcription FactorsHumansImmunotherapyLymphocyte ActivationNeoplasmsPhenotypeRadiation, IonizingT-Lymphocytes, CytotoxicT-Lymphocytes, RegulatoryTransforming Growth Factor beta1CTLA-4 AntigenForkhead Transcription FactorsTransforming Growth Factor beta1Cancer immunotherapyRadiationRegulatory T cellsTREGS

Identifiers

PMID32299365
PMCPMC7164225
OpenAlexW3016834067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.